approaches to identifying individuals with undiagnosed …c.ymcdn.com/sites/ · approaches to...

46
National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) TTASC | Training and Technical Assistance Support Center Approaches to Identifying Individuals with Undiagnosed HTN Evaluation Peer Learning Community: Health Systems and Clinical- Community Linkages April 20, 2017 2:00-3:00PM EST

Upload: vuongnguyet

Post on 10-Apr-2018

218 views

Category:

Documents


3 download

TRANSCRIPT

National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)TTASC | Training and Technical Assistance Support Center

Approaches to Identifying Individuals with Undiagnosed HTN

Evaluation Peer Learning Community: Health Systems and Clinical-Community Linkages

April 20, 2017

2:00-3:00PM EST

Agenda

• Panel Presentation

◦ Wisconsin

◦ Arizona

◦ Los Angeles County

• Group Discussion

2

UNDIAGNOSED HYPERTENSION IN WISCONSIN

Mary Pesik, Chronic Disease Prevention Unit Director

3

UNDIAGNOSED

HYPERTENSION IN

WISCONSINMary Pesik

Chronic Disease Prevention Program Director

Wisconsin Department of Health Services,

Division of Public Health

April 20, 2017

Today’s Outline: 100 Meter Dash of

Wisconsin’s Experience

Undiagnosed

Hypertension

Basic 5

Intent

Health Plans

Association

of State and

Territorial

Health

Officials

(ASTHO)

Lessons

LearnedChallenges

Federally

Qualified

Health Centers

(FQHCs)

Clinics and

Providers

How it began…

Basic strategy 5 intent and activity modifications

Approach and partnerships to consider

Chronic Disease Quality

Improvement Project: Represents

13 of 17 health plans/payers

MetaStar: Represents the quality

improvement network/regional

extension center

Wisconsin Collaborative for

Healthcare Quality: Represents

about 65% of all physicians

Wisconsin Nurses Association:

Represents over 2,200

nurses/nurse memberships

Pharmacy Society of Wisconsin:

Represents community/clinical

pharmacists and pharmacy chains

(over 3,000 members)

Wisconsin Community Health

Fund: Represents a non-profit

organization/public-private

partnership

Wisconsin Primary Health Care

Association: Represents all 18

FQHCs

ASTHO Million Hearts State

Learning Collaborative September 2015 to present

Overview:

Improve identification of undiagnosed persons with high blood pressure (BP)

Rapid cycle improvement using Plan-Do-Study-Act cycles

Health system in one target population site to identify patients hiding in plain sight (HIPS)

Method:

Measurement Period: April 1, 2015 to March 31, 2016

Numerator: Patients no diagnosis of hypertension (HTN) in problem list or electronic health

record (EHR)

Denominator: During the measurement period, patients a) with at least two BP readings with a

systolic ≥140 mm Hg and a diastolic ≥90 mm Hg and b) that had at least two office visits

Results: Identified 10.04% undiagnosed hypertensive patients (84 out of 837)

Next Steps:

Protocols and workflows developed for staff to connect with patients to return and see provider

for rechecks and assessment

Created EHR prompts to guide staff/providers to address HTN and other chronic diseases

Definitions & Guidance

1) NorthShore University Health System

2) Geisinger Health

3) Palo Alto Medical Foundation

4) University of West Virginia

5) University of Wisconsin

6) National Association of Community Health Centers’

(NACHC) Undiagnosed Hypertension Change Package

FQHCs

Overview:

Wisconsin Primary Health Care Association (WPHCA)

Azara DRVS (Data Reporting & Visualization System)

Method:

NACHC Undiagnosed Hypertension Change Package (3 FQHCs)

Measurement Period: June 2015 to June 2016

Numerator: Patients who had at least one Stage 2 BP reading or at least two Stage 1 BP

readings during the measurement period

Denominator: All patients age 18-85 who do not have a HTN diagnosis (excluding pregnant

and ESRD patients) and had an office visit during the measurement period

Results:

Identified 8.96% undiagnosed hypertensive patients (559 out of 6,238)

Next Steps:

More FQHCs utilizing Azara DRVS

Current FQHCs can utilize the registry and “visit planning” reports for HIPS patient follow-up

Clinics & Providers

Overview:

Wisconsin Collaborative for Healthcare Quality (WCHQ)

Public quality reporting and Repository Based Data Submission tool

Method: Geisinger Health System & Palo Alto Medical Foundation approaches (19 health systems)

Measurement Period: January 1, 2015 to December 31, 2015

Numerator: a) Patients with a problem list diagnosis (active problem), and/or b) encounter file

diagnosis, and/or two elevated BP readings…

Geisinger Only: c) with both systolic ≥140 mmHg or both diastolic ≥90 mmHg

Palo Alto Only: c) with either systolic ≥140 mmHg or diastolic ≥90 mmHg

Denominator: Patients with at least one office visit and has elevated BP (as defined by each

approach) without a diagnosis of HTN in either the problem list or encounter file during the

measurement period

Results:

Geisinger: Identified 21.20% undiagnosed hypertensive patients (167,129 out of 788,315)

Palo Alto: Identified 21.71% undiagnosed hypertensive patients (172,279 out of 788,315)

Next Steps: Explore potential refinements to measurement approach and investigate feasibility of

developing a standardized measure for statewide, public reporting (like NQF 18 and 59)

Challenges & Lessons Learned

Multiple definitions and

algorithms

Acknowledgement of

issue

Buy-in regarding

method/algorithm used

Not a single request

Time

Unable to compare or

cumulate data

Data proves the problem

Constant quality

improvement process

A little can go a long

ways

Challenges Lessons Learned

Mary Pesik, RDN, CD

Chronic Disease Prevention Program Director

[email protected]

608-267-3694

Thank you!

ARIZONA’S EFFORTS WITH IDENTIFYING PATIENTS WITH UNDIAGNOSED HYPERTENSION

Michelle Sandoval-Rosario, Senior Epidemiologist

David Heath, Heart Disease and Stroke Prevention Manager

13

Arizona’s Efforts With Identifying Patients with Undiagnosed Hypertension

David Heath, MBA

LCDR Michelle Sandoval-Rosario, MPH, CPH

Overview• Background

• Year 3 Pilot

• Year 4

• Clinical Definitions

• Results

• Challenges

• Lessons Learned

Background• Pre 1305

– 2012 Meaningful Use Analysis of FQHC’s HIT Capacity

• First started evaluating clinic’s capacity to track NQF measures

• Included NQF 13 (HTN x2 Visits per year)

• Multiple vendors; wide range of capacity and training

• Partnerships– Collaborative relationship established with FQHCs, non-FQHC clinics, State QIO

• Leveraging 1305 activities– Integrated the reporting of NQF 18 and 59 into most projects that occur in the

healthcare setting

• CHW projects

• Team based care projects

• Reinforced what was learned in the 2012 capacity analysis – some are ready, some are not

Year 3 Pilot and Year 4• 1305 Year 3 Pilot

– Selected non-FQHC community health center to pilot an EHR enhancement

• Regional Centers for Border Health (RCBH) , Yuma, AZ. Creation of a virtual “portal” to create easy, chronic care management dashboards by patient or by specified patient population. Sorted by provider, condition, etc.

– Results were very good. Clinic optimized information to target high risk patients.

– Selected RCBH to run reports on undiagnosed HTN after providing definitions and parameters.

• 1305 Year 4 – Mirrored EHR portal development with new clinic – St Vincent De Paul

• Portal currently being “built”

– Challenged 5 other 1305 participants to report on undiagnosed HTN through inclusion of “required” performance measure reporting, in addition to their contractually obligated reports on NQF18, self management, etc.

1305 Clinical Definitions

• Proportion of adults in the state aware they have high blood pressure (B.5.01): – Numerator: the number of adults who have been diagnosed with HTN

– Denominator: Total number of adults patients with HTN (diagnosed and undiagnosed)

• Embedded algorithms into EHR to identify patients greater than 18 years old at risk for undiagnosed HTN– Definition: two or more non-consecutive blood pressure readings

of >140/90 mm HG who did not have documentation of HTN

Year 3 Pilot Findings

• Between 09/01/2015 – 07/31/2016

– 966 patients identified with HTN (diagnosed and undiagnosed)

– 14% (138) undiagnosed

– 51% Females and 93% Hispanic

– 52% with controlled HTN

Year 4 Findings

• Five additional health systems Health System

(HS)# of patients with 2 or more blood pressure

readings ≥ 140/90

# diagnosed and undiagnosed with

High blood pressure

Percent Undiagnosed

HS 1 77 256 30%

HS 2 92 386 24%

HS 3 159 2218 7%

HS 4 84 1773 5%

HS 5 46 4305 1%

Challenges

• Still need to verify undiagnosed hypertension

• Health System’s EHR capacity or IT support

• Lack of awareness/resources

• Clinical criteria– Undiagnosed HTN

– HTN Self Management Program

• Health system definition

Lessons Learned

Partnerships

Identify EHR capabilities

Establish definition and clinical criteria

Provide on-going technical

assistance and guidance

Develop a plan to address

patients with high blood pressure

Identifying Patients with Undiagnosed HTN

ADDRESSING HYPERTENSION IN LOS ANGELES COUNTY

Tony Kuo, Acting Director

Noel Barragan, Manager

24

Addressing Hypertension in Los Angeles County

Thursday, April 20, 2017

Tony Kuo, MD, MSHS

Acting Director

Noel Barragan, MPH

Manager, Special Projects and Strategic Initiatives

Division of Chronic Disease and Injury Prevention

Los Angeles County Department of Public Health

26

Los Angeles County

The Landscape• 4,000 square miles

•10 million residents• 23% hypertension• 10% diagnosed diabetes• 40% with prediabetes• 17% poverty

•88 cities •City of Los Angeles ~ 3.5 million residents

•80 schools districts + LACOE

•Opportunity for broad reach

Undertreated or Uncontrolled Hypertension

• Patients ages 18 to 85 years with a diagnosis of hypertension (in EMR or Blood Pressure [BP] registry) who have BP readings >140mmHg SBP or >90mmHg DSP at any one medical visit during the past 12 months, regardless of whether they are on medications or not

Exclusions: pregnancy and end stage renal disease.

Source: Million Hearts – National Association of Community Health Centers

27

Undiagnosed Hypertension

• Two or more office visits after an initial screen

• Stage 1: Patients ages 18 to 85 years without a diagnosis of HTN (documented as an ICD‐9 assessment of 401‐405 at an encounter) who have BP readings >140mmHg SBP or >90mmHg DSP at two separate medical visits, including the most recent visit, during the past 12 months

• Stage 2: Patients ages 18 to 85 years without a diagnosis of HTN (documented as an ICD‐9 assessment of 401‐405 at an encounter) who have BP readings >160mmHg SBP or >100mmHg DSP at any one medical visit during the past 12 months

Exclusions: pregnancy and end stage renal disease

Source: Wall et al. JAMA 2014;312(19):1973-1974 28

“Safety Net” Health Systems in Los Angeles

Los Angeles County Department of Health Services

• Second largest municipal health system in the nation

• Annually cares for 670,000 unique patients

• 19 health centers, 4 hospitals, network of community partner clinics

Community Clinics (FQHCs):AltaMed Health Services

• California’s largest non-profit Federally Qualified Health Center

• More than 950,000 annual patient visits

• 43 sites in Los Angeles and greater Southern California

29

DPH’s Approach

Provide Technical

Assistance

Engage with Leadership

Provide Funding

Support for Protocol/Tool Development

30

Existing Polices and Efforts in California

• California Senate Bill 493

• California Department of Public Health

• LA Barbershop

• American Heart Association, Western States Affiliate Blood Pressure Task Force

31

Key Stakeholder Survey

• Opportunities to Align Advanced Community Pharmacy Practice with Unmet Healthcare Needs

• Representatives from: retail chain pharmacies, independent community pharmacies, academia, professional organizations, non-profit organizations, insurance/payers, and local health departments

• Opportunities for pharmacists to meet the chronic disease needs of communities and strategies to scale-up advanced pharmacy practices such a MTM/CMM effectively in LA

32

Key Stakeholder Survey: Methods

• All participants were asked to complete a 17-item paper questionnaire

• Closed and open-ended questions that took approximately 10 minutes to complete

• Participant perspectives on priority actions needed to scale-up pharmacist-led patient care activities

• Organizational readiness for implementing such systems or models of practice

• Current barriers to delivering MTM/CMM services

33

Key Stakeholder Survey: Results

• 26 of 56 attendees (46%) completed the survey.

• About half reported their level of experience as at least 11 years or more (n=13)

• More than 40% self-identified as a pharmacists or members of pharmacy leadership in California (n=11)

• Rated the following as top priority actions:

• Improve reimbursement procedures or options among private insurers

• Advance federal policy at the Centers for Medicare and Medicaid Services to expand coverage of pharmacists’ services

• Increase healthcare provider awareness of and receptivity to pharmacists’ services

34

Key Stakeholder Survey: Results

• Barriers associated with the scale-up and spread of pharmacist-led patient care services

• Reimbursements for most services remain siloed based on health plan policies which are generally physician-centric

• There is a lack of interoperable electronic medical record systems that facilitate seamless pharmacist-physician communications

• Standard clinic workflows do not readily integrate pharmacists into the healthcare team

• Lack of awareness and support by prescribing physicians for MTM/CMM services

• Perceived limited public acceptance of non-physician extenders as a treating provider

35

Public Opinion Internet Panel Survey: Methods

36

• Internet panel survey of adult residents living in LA

• Awareness of having access to MTM at usual healthcare facility?

• Potential interest in receiving MTM services if made available to them?

Public Opinion Internet Panel Survey: Results

37

• 1,014 completed the survey

• Adjusted response rate = 58%

• Demographics

• Ages of 25-64 (71%)

• Female (51%)

• Hispanic (43%), White (30%)

• Some college education (56%)

• Excellent/very good health (56%)

• Overweight/obese (54%)

• At least two chronic conditions (35%)

Public Opinion Internet Panel Survey: Results

38

• Approximately 9% reported knowledge of having access to MTM services where they usually go for care

• 2% had used MTM

• 41% expressed interest in using MTM services, regardless of what was currently available

• Among participants who expressed interest in using MTM, 51% were female, 54% reported excellent to very good health, and 86% said they were generally comfortable speaking to a pharmacist.

Public Opinion Internet Panel Survey: Results

• Predictors of interest in MTM (binary logistic model)

• Older age (65+) positively predicted interest, p=0.02

• Awareness of access to MTM services negatively predicted interest, p<0.00

• Comfort speaking with a pharmacist negatively predicted interest, p<0.00

• Results speak to the challenges of developing client interest in MTM services and the complexities of patient decision-making

39

Continuing Medical Education Module

• Sponsored the development and launch of a continuing medical education module to increase physician understanding of MTM/CMM and its potential benefit to the healthcare team.

40

White Paper/Toolkit

41

• Collaborated with AltaMed to develop a toolkit for incorporating MTM/CMM in clinical practice

• Algorithms for patient identification and treatment, clinic workflows, patient scripts

Lessons Learned…

• Public awareness

• Provider buy-in

• Full program development versus incremental but across system investment

• Implementation barriers – reimbursement, length of time to change healthcare provider behaviors, issue of patient adherence, system incentives, lack of coordinating infrastructure, EHR

• Language translation needs, cultural competency, health literacy

• Health equity

42

Next Steps…

• Work with local clinic and pharmacy partners to pilot these protocols and workflows, and to evaluate their impact

• Included in the evaluation will be measures to study patient interest in and receptivity to these services

• Disseminate toolkit and expand access to CME module

43

Thank YouContact Information

[email protected]@ph.lacounty.gov

Breakout Discussion

• What has your experience been with identifying individuals with undiagnosed or undertreated HTN?

• For 1305 grantees, how have you identified state-wide systems?

◦ How do you approach this using a state wide definition of health system?

• How do you define undiagnosed HTN? Undertreated HTN?

• What stakeholder groups have you engaged in your efforts?

45

Thank you!

• Want to talk further with your peers? Email or visit the Google Group!

[email protected]

◦https://groups.google.com/d/forum/eplc-hs-ccl

• Have a question for our community administrators? Contact us at [email protected]

46